Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry

Alzheimer disease (AD) is a leading cause of dementia that has gained prominence in our aging society. Yet, the complexity of diagnosing AD and measuring its invasiveness poses an obstacle. To this end, blood-based biomarkers could mitigate the inconveniences that impede an accurate diagnosis. We de...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeongshin, Kim, Jaenyeon, Son, Minsoo, Lee, Jihyeon, Yeo, Injoon, Choi, Kyu Yeong, Kim, Hoowon, Kim, Byeong C., Lee, Kun Ho, Kim, Youngsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786819/
https://www.ncbi.nlm.nih.gov/pubmed/35075217
http://dx.doi.org/10.1038/s41598-022-05384-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786819/
https://www.ncbi.nlm.nih.gov/pubmed/35075217
http://dx.doi.org/10.1038/s41598-022-05384-8

Ejemplares similares